You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BAVENCIO®

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear-Cell Renal Carcinoma Trial run by the NCI (rhIL-15, Avelumab)

Terminated
Has Results
  • Clear-Cell Renal Carcinoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 27, 2022

Urothelial Carcinoma Trial (Avelumab)

Not yet recruiting
  • Urothelial Carcinoma
  • (no location specified)
Oct 26, 2022

Breast Cancer Trial (Avelumab, Aspirin, Lansoprazole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Feb 2, 2023

Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)

Active, not recruiting
  • Leptomeningeal Metastases
  • Leptomeningeal Disease
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022

Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)

Active, not recruiting
  • Meningioma
  • Meningioma, Adult
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 27, 2022

Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

Active, not recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +1 more
Oct 10, 2022

Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

Completed
  • Solid Tumor, Adult
  • Minneapolis, Minnesota
  • +2 more
Jan 27, 2023

Refractory Cancer, Metastatic Cancer, Recurrent Cancer Trial in Santa Monica (SNK01, Avelumab, Pembrolizumab)

Active, not recruiting
  • Refractory Cancer
  • +6 more
  • SNK01
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Research Center
Sep 25, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)

Terminated
  • POLE Exonuclease Mutant Colon Cancer
  • +2 more
  • Sutton, Surrey, United Kingdom
    Royal Marsden NHS Foundation Trust
Oct 5, 2022

Cervical Cancer Trial in Hong Kong (Avelumab, Axitinib)

Recruiting
  • Cervical Cancer
  • Hong Kong, Hong Kong
    The University of Hong Kong
Feb 23, 2022

Axitinib Therapy Management Study

Withdrawn
  • Renal Cell Carcinoma
  • New York, New York
    Pfizer Inc.
Mar 25, 2022

Metastatic Castration-resistant Prostate Cancer Trial in New Orleans (Avelumab, 2nd generation ADT (abiraterone or

Terminated
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Avelumab
  • 2nd generation ADT (abiraterone or enzalutamide)
  • New Orleans, Louisiana
    Tulane University School of Medicine
Apr 6, 2022

Cancer, Tumors, Tumors Trial in Denmark (Alectinib, Atezolizumab, Avelumab)

Recruiting
  • Cancer
  • +3 more
  • Aalborg, Denmark
  • +6 more
Oct 25, 2022

Urothelial Carcinoma Trial in Irvine, Dallas, Houston (MRx0518, Avelumab 20 mg/mL Intravenous Solution (IV))

Active, not recruiting
  • Urothelial Carcinoma
  • MRx0518
  • Avelumab 20 mg/mL Intravenous Solution (IV)
  • Irvine, California
  • +2 more
Jul 5, 2022

Head and Neck Squamous Cell Carcinoma Trial in La Jolla (Avelumab, Palbociclib, Cetuximab)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
Feb 16, 2022

Small Cell Lung Carcinoma Trial in Greece (Avelumab)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • Chaïdári, Athens, Greece
  • +5 more
Apr 18, 2022

Cancer Trial in Heidelberg, Mainz (combination of Avelumab and Cabozantinib)

Recruiting
  • Cancer
  • combination of Avelumab and Cabozantinib
  • Heidelberg, Germany
  • +1 more
Mar 31, 2022

Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Scottsdale, Arizona
  • +4 more
Dec 27, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Gyeonggi-do, Seoul (GEN-001, Avelumab)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Gyeonggi-do, Korea, Republic of
  • +4 more
Jun 14, 2022

Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

Recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +3 more
Apr 15, 2022

NSCLC Metastatic, NSCLC Stage III Trial in Worldwide (Avelumab, Axitinib, Palbociclib)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Non-small Cell Lung Cancer Stage III
  • La Jolla, California
  • +5 more
Aug 12, 2022

Solid Tumor, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck Trial in New Haven, Atlanta, Portland

Recruiting
  • Solid Tumor
  • +3 more
  • New Haven, Connecticut
  • +2 more
Aug 1, 2022

Esophageal Tumor, Metastatic Esophageal Squamous Cell Carcinoma Trial in Taipei (Avelumab)

Enrolling by invitation
  • Esophageal Tumor
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Taipei, Taiwan
    National Taiwan University Hospital, Taiwan
Sep 6, 2021

Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML

Recruiting
  • Non Small Cell Lung Cancer
  • Solid Tumor
  • Jette, Brussels, Belgium
  • +1 more
Sep 9, 2022